540726
TTFL
Start SIP
Invest Now
Start SIP in TTFL
Trident Texofab live price: ₹61.15. It opened at ₹61 vs previous close ₹64; intraday high/low: ₹61/₹61. The 50 & 200 DMA stand at ₹168.56/₹224.09.
Trident Texofab Performance
- Low
- ₹61
- High
- ₹61
- 52 Week Low
- ₹61
- 52 Week High
- ₹379
- Open Price₹61
- Previous Close₹64
- Volume960
- 50 DMA₹168.56
- 100 DMA₹213.23
- 200 DMA₹224.09
Investment Returns
- Over 1 Month -64.01%
- Over 3 Month -81.59%
- Over 6 Month -76.11%
- Over 1 Year -63.62%
Smart Investing Starts Here Start SIP with Trident Texofab for Steady Growth!
Trident Texofab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.4
- PEG Ratio
- 0.4
- Market Cap Cr
- 92
- P/B Ratio
- 1.6
- Average True Range
- 6.68
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -37.38
- RSI
- 4.91
- MFI
- -
Trident Texofab Financials
Trident Texofab Technicals
EMA & SMA
Current Price
₹61.15
-3.21
(-4.99%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹106.71
- 50 Day
- ₹168.56
- 100 Day
- ₹213.23
- 200 Day
- ₹224.09
Resistance and Support
61.15
- R3 61.15
- R2 61.15
- R1 61.15
- S1 61.15
- S2 61.15
- S3 61.15
Trident Texofab Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-12 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | (Revised) |
| 2025-05-29 | Audited Results | |
| 2025-02-03 | Quarterly Results |
Trident Texofab F&O
About Trident Texofab
- NSE Symbol
- TTFL
- BSE Symbol
- 540726
- Chairman & Managing Director
- Mr. Hardik Jigishkumar Desai
- ISIN
- INE071Y01013
Similar Stocks to Trident Texofab
Trident Texofab FAQs
Trident Texofab share price is ₹61 As on 07 March, 2026 | 06:51
The Market Cap of Trident Texofab is ₹91.7 Cr As on 07 March, 2026 | 06:51
The P/E ratio of Trident Texofab is 28.4 As on 07 March, 2026 | 06:51
The PB ratio of Trident Texofab is 1.6 As on 07 March, 2026 | 06:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.